Originating new discoveries
NoAb BioDiscoveries’ experienced Genomic team of scientists is focused on determining the effects of xenebiotic compounds on the patterns of gene expression in human cell lines and primary human hepatocytes. These research efforts are supported through the microarray technology and bioinformatics.

NoAb recently developed and launched DTEx™, a proprietary technology for profiling the effects of xenobiotics on drug transporter, Phase I and II enzymes and nuclear X receptor gene expression.